Sunil Healthcare Limited (BOM:537253)
India · Delayed Price · Currency is INR 69.00
-1.00 (-1.43%)
At close: Feb 12, 2026
Sunil Healthcare Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
| 892.01 | 834.21 | 901.92 | 1,105 | 1,192 | 906.2 | |
Revenue Growth (YoY) | 6.79% | -7.51% | -18.37% | -7.28% | 31.50% | 29.42% |
Cost of Revenue | 359.82 | 379.03 | 486.28 | 501.59 | 522.31 | 452.44 |
Gross Profit | 532.19 | 455.18 | 415.64 | 603.32 | 669.33 | 453.76 |
Selling, General & Admin | 135.03 | 124.35 | 130.57 | 149.15 | 143.89 | 127.02 |
Other Operating Expenses | 241.59 | 211.18 | 242.47 | 289.13 | 315.46 | 245.78 |
Operating Expenses | 442.83 | 399.31 | 433.89 | 511.58 | 554.35 | 433.94 |
Operating Income | 89.36 | 55.88 | -18.25 | 91.74 | 114.99 | 19.82 |
Interest Expense | -52.99 | -57.01 | -47.5 | -33.32 | -25.54 | -44.97 |
Interest & Investment Income | 3.28 | 3.28 | 2.55 | 2.11 | 2.16 | 3.18 |
Currency Exchange Gain (Loss) | -13.7 | -13.7 | 11.53 | 12.79 | 7.06 | - |
Other Non Operating Income (Expenses) | 2.56 | -6.72 | -9.24 | -5.55 | -9.29 | 5.68 |
EBT Excluding Unusual Items | 28.52 | -18.26 | -60.92 | 67.77 | 89.38 | -16.3 |
Gain (Loss) on Sale of Investments | - | - | - | 0.05 | 0.63 | 0.22 |
Gain (Loss) on Sale of Assets | -1.05 | -1.05 | -1.73 | 0.9 | -0.01 | -0.6 |
Other Unusual Items | 7.15 | 7.15 | 8.96 | 26.12 | 2.66 | 11.15 |
Pretax Income | 34.62 | -12.16 | -25.55 | 94.83 | 92.65 | -5.53 |
Income Tax Expense | 6.09 | 2.01 | -7.67 | 28.01 | 28.44 | 0.85 |
Earnings From Continuing Operations | 28.53 | -14.17 | -17.89 | 66.82 | 64.21 | -6.38 |
Net Income | 28.53 | -14.17 | -17.89 | 66.82 | 64.21 | -6.38 |
Net Income to Common | 28.53 | -14.17 | -17.89 | 66.82 | 64.21 | -6.38 |
Net Income Growth | - | - | - | 4.07% | - | - |
Shares Outstanding (Basic) | 10 | 10 | 10 | 10 | 10 | 10 |
Shares Outstanding (Diluted) | 10 | 10 | 10 | 10 | 10 | 10 |
EPS (Basic) | 2.78 | -1.38 | -1.74 | 6.52 | 6.26 | -0.62 |
EPS (Diluted) | 2.78 | -1.38 | -1.74 | 6.52 | 6.26 | -0.62 |
EPS Growth | - | - | - | 4.07% | - | - |
Free Cash Flow | - | 20.89 | -258.62 | 32.67 | 134.73 | 101.44 |
Free Cash Flow Per Share | - | 2.04 | -25.22 | 3.19 | 13.14 | 9.89 |
Gross Margin | 59.66% | 54.56% | 46.08% | 54.60% | 56.17% | 50.07% |
Operating Margin | 10.02% | 6.70% | -2.02% | 8.30% | 9.65% | 2.19% |
Profit Margin | 3.20% | -1.70% | -1.98% | 6.05% | 5.39% | -0.70% |
Free Cash Flow Margin | - | 2.50% | -28.67% | 2.96% | 11.31% | 11.19% |
EBITDA | 157.74 | 119.25 | 38.44 | 155.1 | 175.38 | 79 |
EBITDA Margin | 17.68% | 14.29% | 4.26% | 14.04% | 14.72% | 8.72% |
D&A For EBITDA | 68.38 | 63.37 | 56.7 | 63.36 | 60.39 | 59.18 |
EBIT | 89.36 | 55.88 | -18.25 | 91.74 | 114.99 | 19.82 |
EBIT Margin | 10.02% | 6.70% | -2.02% | 8.30% | 9.65% | 2.19% |
Effective Tax Rate | 17.59% | - | - | 29.54% | 30.70% | - |
Revenue as Reported | 914.68 | 847.6 | 954.12 | 1,150 | 1,208 | 961.99 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.